Three-decade investment professional with experience in US public stocks, leveraged buyouts and venture capital. CEO of Cestrian Capital Research, Inc.
Pfizer ( PFE ) – Q3 2025 Review
The Stock That Fell To Earth
Vertiv Holdings Q3 FY12/25 Earnings Review
Still Racking Up The Wins
Market On Open, Thursday 8 January
Wider, Deeper Coverage Starts Today
Metals On Open, Wednesday 7 January
BTFD x WW3
In Pursuit Of Entropy: The Trade Desk ($TTD) Q3 Earnings Review
What Next For The Worst Performing Stock Of 2025?
Market On Open, Tuesday 6 January
Goldilocks?
Q: Is There A Generational Opportunity In Biotech Stocks?
Biotech 2026 = Tech 2023?
Regeneron (REGN) – Q3 2025 Review
Eyeing A Breakout?
Getting A Little Too Exciting? Read On!
Don’t Sleep On Income Opportunities.
Market On Open, Sunday 4 January
DISCLAIMER: This note is intended for US recipients only and,